March 14, 2017
Market analyst puts focus on four major players in the Drug Manufacturers space
Ahead of Tuesday’s trading session, Stock-Callers.com puts focus on four major players in the Drug Manufacturers space.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Impax Laboratories
March 7, 2017
Biotech, pharma stocks rise driven by acquisitions and new products
Notable news in the pharmaceutical and biotech markets includes a slew of mergers and acquisitions, new drug trails and product launches as industry leaders search for competitive advantage and increased revenue streams.
November 27, 2015
EU opens door for Impax’s Parkinson’s treating oral capsule Numient
Impax Laboratories has been granted by the European Commission (EC) authorization to market its Numient oral capsule formulation for the symptomatic treatment of adult patients with Parkinson’s disease.